telmisartan has been researched along with Hepatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cynis, H; Demuth, HU; Fujii, M; Haegele, M; Heiser, U; Hoffmann, T; Kehlen, A; Schilling, S; Shibazaki, Y; Yoneyama, H | 1 |
1 other study(ies) available for telmisartan and Hepatitis
Article | Year |
---|---|
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.
Topics: Aminoacyltransferases; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Line, Tumor; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Fatty Liver; Hepatitis; Human Umbilical Vein Endothelial Cells; Humans; Leukemia, Monocytic, Acute; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Telmisartan | 2013 |